A Preliminary Report on the Thymidine Labeling Indices and Kinetics of Cell Proliferation in Selected Morris Hepatomas by Looney, W. B. et al.
826
A PRELIMINARY REPORT ON THE THYMIDINE LABELING
INDICES AND KINETICS OF CELL PROLIFERATION IN
SELECTED MORRIS HEPATOMAS
W. B. LOONEY, A. A. MAYO, M. Y. JANNERS, J. G. MELLON, P. ALLEN,
D. SALAK, AND H. P. MORRIS
From the Division ofRadiobiology andBiophysics, Departments ofPediatrics andRadiology
(W.B.L., A.A.M., M.Y.J., and J.G.M.); Department of Clinical Pathology and Division
of Biomedical Engineering (P.A.); University of Virginia School of Medicine, Charlottes-
ville, Virginia 22901; University of Virginia Computer Science Center (D.S.); and Depart-
ment of Biochemistry, Howard University, College of Medicine, Washington, D.C. 20001,
U.S.A.
Received for publication July 1, 1970
SUMMARY.-The 1 hour thymidine labeling indices have been determined for
8 hepatomas which have growth rates which vary by a factor of 14. The indices
for these tumors vary only by a factor of 4. Little correlation was found.
Preliminary results have been obtained on the kinetics of cell proliferation of
the rapidly growing Hepatoma H-35tc2. The tumor transfer time is 07 months
and the growth rate is 7*0 cm. per month. The calculated values for times in
different phases ofthe cell cycle for H-35tc2, assuming a log normal distribution
for phase duration, were as follows: Tgl (Gap I)-11.0 hours; T. (DNA synthetic
period)-6-6 hours; Tg2 (Gap II)-4*2 hours; Tm (mitotic time)-0.4 hours.
Therefore, the total time, Tc, for one cell cycle was calculated to be 22*2 hours.
The potential doubling time was calculated to be 43 hours. The GF (growth
fraction) was estimated to be 53 per cent which would suggest that approxi-
mately one-half the total cell population is nonproliferating.
THE availability ofalargeseriesofchemicallyinducedhepatomas haspermitted
a rather broad investigation of the problem of neoplastic transformation. One
of the authors (H.P.M.) has made available to numerous investigators some 35
different tumor lines which have more than a 20-fold difference in growth rate
aswell as marked differences inthe frequency and magnitude ofgenetic, metabolic,
and morphological deviations (Morris, 1965).
Preliminary studies have been made on the relative rates of incorporation of
tritium labeled thymidine into nuclear DNA by 4 of these hepatoma lines which
have considerable differences in growth rates (Looney and Mayo, 1969; Chang,
Morris and Looney, 1968). It might be expected that the thymidine labeling
index for the faster growing tumors would be greater than for the slower growing
tumors. However, the 1 hour thymidine labeling indices for the 4 hepatomas were
found to be similar even though the growth rates (tumor transfer times) vary by a
factor of 4.
For this reason, we have initiated studies of the kinetics of cell proliferation
and cell loss in these tumors, in the hope that an understanding ofthese processes
will allow us to better utilize radiation and chemotherapeutic agents in the clinical
management ofneoplastic disease. Changes in the approach to the treatment of
cancercouldoccurasaresultofourmorepreciseunderstandingofhowtumorsgrow.CELL PROLIFERATION IN MORRIS HEPATOMAS
In this paper, we report the results of the cell proliferation measurements on
Hepatoma H-35tc2 and supplemental information on labeling indices of tumors
with different growth rates.
MATERIALS AND METHODS
ACI strain female rats, each weighing approximately 150 g., were inoculated
bilaterally and subcutaneously in the back with Hepatoma H-35tc2. Fifty ,uCi
of thymidine-5-methyl-3H (3 ,uCi/mmole), at a concentration of 0-017 micromole
per ml. in normal saline solution, was given to each rat by i.p. injection. The
tumors measured 2-3 cm. in the longest dimension at the time ofthe experiment.
All rats were injected between 8.00 and 9.00 a.m. in order to avoid the introduction
of error due to daily oscillations in thymidine metabolism which have been
reported by Potter (1967).
Hepatoma H-35tc2 is a poorly differentiated, rapidly growing tumor (tumor
transfer time 0 7 months) with a considerable enzymatic andbiochemical deviation
from normal liver.
Following sacrifice, tumors were fixed in 10 per cent formalin for 72 hours and
then stored in 70 per cent alcohol. The sections were later embedded in paraffin,
sectioned at 4 microns, and stained with hematoxylin and eosin. Kodak AR-10
stripping film was applied and the slides were stored in black boxes at 4° C.
They were developed in Kodak D-19 developer and fixed in a 20 per cent solution
of sodium thiosulfate. The autoradiographs were exposed for varying periods
of time in order to maintain 20-30 silver grains per cell. The grain counts per
labeled cell in mitoses have also been carried out and compared to the grain counts
per nonmitotic labeled cell. The results were similar. A 14-day exposure was
necessary for the autoradiographs of the tumors that had been fixed prior to
16 hours after injection. The exposure time had to be increased to 28 days for the
tumors that had been fixed 30-34 hours after thymidine injection and to 42 days
for the tumors which had been fixed 40 through 70 hours after injection. Three
slides were counted for each tumor; 750 cells per slide were counted to determine
per cent labeled cells; 50 mitoses per slide were counted to determine per cent
labeled mitoses. This resulted in a total of 2250 cells counted per tumor and
150 mitoses per tumor.
The cell cycle time and the time intervals for the different phases of the cell
cycle have been calculated for the rapidly growing Hepatoma H-35tc2. Esti-
mates ofthe different phases ofthe cell cycle have been analyzed by four different
methods: (1) fitting of data points individually to polynomials by the method of
least squares, (2) measurement of the time between the mid peak of the first and
second waves ofper cent labeled mitoses, (3) average ofthe 50 per cent intercepts
of the two ascending limbs and the 50 per cent intercepts on the two descending
limbs of the curves of per cent labeled mitoses, (4) determination of the phase
deviations assuming a log normal distribution for the deviation of the phases.
The calculations based on the computer program of Barrett (1966) for producing
optimum curves have been used in the calculations for other parameters.
We have also determined the 1 hour thymidine labeling index for Hepatomas
R-7, 7797, 9611B, and 8999. This was carried out in a manner similar to that
employed in previous determinations of thymidine labeling indices (Looney and
Mayo, 1969; Chang, Morris and Looney, 1968). At least 250 cells from each of
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3 squashes (i.e. 750 cells per tumor) were counted to determine the 1 hour thymi-
dine labeling indices.
RESULTS
The 1 hour thymidine labeling index has been determined for 8 hepatomas
which have growth rates which vary by a factor of 14 (Table I). The 1 hour
thymidine labeling indices in these tumors vary only by a factor of 4. The
chromosome numbers for the various tumors which have been determined by
Nowell, Morris and Potter (1967) have been included in Table I in order to deter-
mine if any correlation could be made between the chromosome number and the
TABLE I
Exp.
Hepatoma No.
3924A . 428
3924A . 438
439
H-35tc2 . 432
433
434
H-35tc2 . 432
433
434
H-35 . 431
H-35 . 437
440
9121 . 472
473
475
9121 . 473
475
R-7 . 527
9611B . 528
7787 . 527
8999 . 528
Date of
exp.
1.31.67
4.8.67
4.10.67
3.1.67
3.17.67
3.20.67
3.1.67
3.17.67
3.20.67
2.22.67
4.7.67
4.11.67
7.26.67
7.31.67
8.5.67
7.31.67
8.5.67
9.10.69
9.11.69
9.10.69
9.11.69
Tumor
growth
(cm.
month)
8-4
8-4
Tumor
transfer
time
(months)
0-6
0-6
Tumor
gen.
2342
. 2342
Thymi-
dine*
labeling
index
(1 hour)
8-9
. 12-9
Standard
error of
mean
. +0-6
. ±2-0
7*0 . 0-7 . 51 . 10-1 . ±1-1
7-0 . 0-7 . 51 . 10-7 . ±1-3
3*0 . 1-7 . 41 . 4.9 . ±0-7 3*0 . 1-7 . 41 . 5-7 . ±1-3
1-6 . 3 0 .142 .13-4 . 0 9
1-6 . 3-0
1.0 . 50
1.0 . 50
0-9 . 9-8
0-6 . 6-0
142 . 13-9 . ±1-4 . 42
18
6
8
133
8-3 . ±0-8
9-6 . ±0- 7
3.3 . ±0-4
4*1 . ±I 1
* Determinations from squashes of minced tumor. Six tumors were routinely used for each
point.
t Nowell, Morris, and Potter, Cancer Re8earch, September, 1967.
TABLE II.-Estimated Duration of Different Phases of the Cell Cycle of H-35tc2
Based on the Change in Per Cent Labeled Mitoses with Time after Labeled
Thymidine Administration
Tg2
Tgl * . .
Tm
Total cell cycle time
(Te) (Hours)
Growth fraction (GF)
Potential doubling time .
(Hours)
Assuming log normal
distribution for
phase duration
(Mean-Hours)
4.2
6-6
11-0
0-4
22-2
53%
43
Average of 50% intercepts
of ascending and
descending limbs
(Mean-Hours)
4-2
7-1
11-2
0-4
22-9
48%
43
Chromo-
somet
number
. 73
. 73
. 52
. 52
43, 44
43,44
42
44
41-44
44
80
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thymidine labeling index. There is no correlation between chromosome number
with the thymidine labeling indices. Little, if any, correlation exists between
growth rates and thymidine labeling indices.
For tumor H-35tc2, the computer programmed analysis which assumes a log
normal distribution ofthe duration ofthe phases ofthe cell cycle, gave a calculated
cell cycle time of approximately 22-2 hours. The calculated time for Tg2 was
4'8 hours; Ts - 6-6 hours; Tgl 11 hours; and Tm O04 hours (Table II).
DISCUSSION
Previous methods by Morris have used the time between tumor transfers as
an index for the differences in growth rates. This ranged between 06 months for
the most rapidly growing tumor 3924A to 13 months for the slowest growing
tumor 7794B. When increased size is computed from increases in the tumor
dimensions measured along two axes, the change in tumor size for rapidly growing
3924A was calculated to be 8-4 cm. per month and for the slow growing 7794B
to be 05 cm. per month. The time between tumor transfer and the rate of
change in tumor size were plotted together (Morris and Wagner, 1968). The time
between transfers was compared with the reciprocal of tumor size per month
graphically. The correlation indicates the two methods of measurement of
change in size and time between inoculation. The average time between tumor
transfer of H-35tc2 is 07 months (range 06-08 months). The change in the
sum ofthe length and width ofH-35tc2 has been estimated by Morris and Wagner
(1968) to be 7 0 cm. per month. It should be noted that two methods are in close
agreement inthat the total cell cycletimes are calculated 22-2 hours and 22-9hours,
respectively.
The values for the different phases in the cycle for H-35tc2 based on the
computer program for producing optimum curves will be used in the following
discussion. The calculated value of 22-2 hours for T, is similar to that found by
Post and Hoffman (1965) in normal liver cells of 3 week old rats. The calculated
value of 22-2 hours based on this method is longer than that found by Lesher
(1967) in his studies ofthe intestinal crypt cells in the mouse. The T, for H-35tc2
of 22-2 hours is also longer than the Tc calculated by Bresciani (1968) to be 14-
16 hours for a chemically induced rat hepatoma, and it is longer than the estimated
T, of 13-8 hours for liver cells of 1 day old rats (Post and Hoffman, 1965).
The estimated value for the DNA synthetic period (Ts) of 6-6 hours is at the
lower limits ofthe Ts period ofa number oftumors which were tabulated by Steel
et al. (1966) and Steel (1968) and which range from 6-18 hours. However, it is
close tothe Ts value of8 hours for most mammalian cells (Steel and Bensted, 1965).
The estimatedvalueforTg2 of4*2 hoursis more thanthe usualformost mammalian
cell lines.
The 1 hour thymidine labeling index was determined for Hepatomas 3924A,
9121 and H-35tc2 in previous studies on the rates of thymidine incorporation
into nuclear and mitochondrial DNA of these tumors between 1967-1968 (Chang,
Morris and Looney, 1968). Two independent determinations for the 1 hour
labeling index for Hepatoma 9121 were 13*9 and 13-4 per cent, respectively. The
1 hour labeling index for Hepatoma H-35tc2 was 10.1 and 10-7 per cent for two
experiments. Therefore, the per cent of labeled cells in the hepatomas is much
greater than the normal liver (0'5 ± 004 per cent) and the 13 hour regenerating
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liver (0 7 ± 1 per cent) before the onset of DNA synthesis. It is less than the
19 1 ± 2-8 per cent labeled liver cells at the peak ofDNA synthesis in regenerating
liver, 21 hours after partial hepatectomy (Looney and Mayo, 1969; Looney,
Chang, and Banghart, 1967).
Steel and Bensted (1965) estimated the potential doubling times of tumors
from the experimental data found on the labeling indices of various tumors and
the time for DNA synthesis. A single equation is utilized to express this relation-
ship based on the assumption that normal liver growth and the distribution of cell
cycle times are invariant. The equation for the Potential Doubling Time is
[T] = T,/L.I. where Ts = time for DNA synthesis hours, L.I. = Labeling Index.
For cell populations in other than linear growth, one must take into account
the fact that the probability of finding a cell in different parts of the cell cycle is
not constant. In the extreme case ofexponential growth, for instance, the phase
distribution diagram is anexponential function. The effect ofthis onthe equation
is to introduce a constant of proportionality. [T]=ATS/L.I. where A must be
found from the shape of the phase distribution diagram. In the case of tumors,
accurate values for A are generally not known, but for a wide range of tumor
doubling times an assumed value of 0-80 appears sufficiently accurate within
+10 per cent. The estimated potential doubling time for H-35tc2 based on this
equation and using the 0-8 value for A is T = 0-8 X 6.6/12.2 = 43 hours.
Estimates ofthe proportion ofproliferating cells in the tumor, which has been
called the Growth Fraction by Mendelsohn (1962), can be made by determining
the ratio ofthe per cent labeled cells to the per cent labeled mitoses. The Growth
Fraction has also been estimated from the ratio ofthe experimentally determined
1 hour thymidine labeling index to the predicted 1 hour thymidine labeling index
in the following manner (Steel, 1968): Predicted labeling index = ATs/Tc where
T= = duration of DNA synthesis and Tc = duration of cell cycle, and A is the
constant of proportionality. The predicted labeling index for H-35tc2 is
0.8 x 6.6/22.2 = 23 per cent.
Experimentally determined 1 hour H3TdR labeling index Growth Fraction Predicted labeling index
The Growth Fraction for Hepatoma H-35tc2 is as follows:
Growth Fraction - 12.2/23 = 53 per cent.
It is interesting to note that the estimated potential doubling time is approxi-
mately twice the cell cycle time and that approximately one-half of the cell
population is estimated to be proliferating cells.
In many instances, the tumor volume doubling time is used synonomously
with cell population doubling time. Steel (1968) has enumerated different
biological processes which can operate to modify this assumption which equates
tumor volume with cell volume. Steel points out that the cell size distribution
could change with time or there could be an accumulation ofintercellular connec-
tive tissue, blood or cystic fluid. Either ofthese processes would obviously make
tumor volume increase faster than the cell population so that the use ofthe volume
doubling time would underestimate cell loss. Crude quantitative estimates of
the relative amounts of connective tissue have been made on some of the Morris
hepatomas. As much as one-third ofthe total tumor ofH-35 might be connective
tissue and incorporated blood vessels whereas tumors 9108 and 9121 both bear a
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close resemblance to normal liver which contains little connective tissue except
in the portal triads.
Steel has also indicated that the effect of overt necrosis needs particular
comment. Any region of dead tissue is probably in a dynamic state, being en-
larged progressively by the addition ofcells that die at its periphery but also being
reduced to some extent by the process ofresorption. The rate of such resorption
is at present difficult to assess. If the necrotic portion of the tumor is constant
over the period of determination oftumor growth rate, then the doubling time of
the whole tumor is the same as its cellular part. However, ifthe necrotic portion
is increasing, then the rate of cell loss will be underestimated.
The rate ofcellloss fromtumors maybe a possibleexplanation for theapparent
discrepancy between tumor growth rates and thymidine labeling indices (Steel,
1968; Denekamp, 1970) (see Table II). Some results have been presented that
suggest that the cell loss increases with tumor size (Clifton and Yatvin, 1969).
Therefore, one of the most significant findings from these hepatoma studies and
from experiments in other laboratories is that cell loss appears to be an important
and hitherto unrecognized factor in the net growth rate oftumors. Unpublished
data from other institutions have show-n that differing and probably erroneous
conclusions may be drawn about the effects of the administration of various
chemotherapeutic agents. This is because of an apparent failure to differentiate
between the cytocidal and cytostatic effects of these agents, and to recognize the
attending critical information to the problem of cell loss (Hofer et al., 1969).
Therefore, these findings may eventually alter our present concepts about the
clinical management of cancer. Measurements of the actual volume doubling
times will be necessary to determine if cell loss is contributing to the net tumor
growth of Hepatoma H-35tc2. These determinations are being made in accor-
dance with the criteria established for the analysis of tumor growth curves by
Dethlefsen, Prewitt and Mendelsohn (1968).
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